Dashboard
Manage Tickers

AVDL AVADEL PHARMACEUTICALS PLC

Nasdaq avadel.com


$ 18.81 $ -0.07 (-0.37 %)    

Thursday, 30-Oct-2025 16:00:23 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 633.96 $ 0.00 (0 %)
DIA $ 475.22 $ 0.00 (0 %)
SPY $ 684.85 $ 0.00 (0 %)
TLT $ 90.29 $ 0.00 (0 %)
GLD $ 368.54 $ 0.00 (0 %)
$ 18.83
$ 18.85
$ 18.53 x 2,000
$ 18.90 x 80
-- - --
$ 6.38 - $ 18.95
2,257,437
na
1.83B
$ 1.25
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-07-2025 03-31-2025 10-Q
3 03-03-2025 01-01-1970 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-08-2024 03-31-2024 10-Q
7 02-29-2024 12-31-2023 10-K
8 11-08-2023 09-30-2023 10-Q
9 08-09-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 03-29-2023 12-31-2022 10-K
12 11-09-2022 09-30-2022 10-Q
13 08-09-2022 06-30-2022 10-Q
14 05-09-2022 03-31-2022 10-Q
15 03-16-2022 12-31-2021 10-K
16 11-08-2021 09-30-2021 10-Q
17 08-09-2021 06-30-2021 10-Q
18 05-10-2021 03-31-2021 10-Q
19 03-09-2021 12-31-2020 10-K
20 11-09-2020 09-30-2020 10-Q
21 08-10-2020 06-30-2020 10-Q
22 05-11-2020 03-31-2020 10-Q
23 03-16-2020 12-31-2019 10-K
24 11-12-2019 09-30-2019 10-Q
25 08-09-2019 06-30-2019 10-Q
26 05-08-2019 03-31-2019 10-Q
27 03-15-2019 12-31-2018 10-K
28 11-05-2018 09-30-2018 10-Q
29 08-07-2018 06-30-2018 10-Q
30 05-04-2018 03-31-2018 10-Q
31 03-16-2018 12-31-2017 10-K
32 11-09-2017 09-30-2017 10-Q
33 08-09-2017 06-30-2017 10-Q
34 05-10-2017 03-31-2017 10-Q
35 03-28-2017 12-31-2016 10-K
36 11-14-2016 09-30-2016 10-Q
37 08-15-2016 06-30-2016 10-Q
38 05-10-2016 03-31-2016 10-Q
39 03-15-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

ubs-downgrades-avadel-pharmaceuticals-to-neutral-maintains-price-target-to-20
UBS Downgrades Avadel Pharmaceuticals to N...
10/28/2025 11:51:44

UBS analyst Ashwani Verma downgrades Avadel Pharmaceuticals (NASDAQ:AVDL) from Buy to Neutral and maintains the price target...

deal-dispatch-from-four-roses-bourbon-to-quantum-stakes-here-are-this-weeks-sector-shake-ups
Deal Dispatch: From Four Roses Bourbon To ...
10/24/2025 16:20:19

Four Roses, Six Flags, and Trump's potential Quantum investments: This week's deal activity involves big bets across va...

leerink-partners-downgrades-avadel-pharmaceuticals-to-market-perform-announces-185-price-target
Leerink Partners Downgrades Avadel Pharmac...
10/23/2025 21:52:33

Leerink Partners analyst Marc Goodman downgrades Avadel Pharmaceuticals (NASDAQ:AVDL) from Outperform to Market Perform and ...

tesla-to-rally-more-than-16-here-are-10-top-analyst-forecasts-for-thursday
Tesla To Rally More Than 16%? Here Are 10 ...
10/23/2025 12:48:03

this-winnebago-industries-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-thursday
This Winnebago Industries Analyst Is No Lo...
10/23/2025 12:32:36

hc-wainwright--co-downgrades-avadel-pharmaceuticals-to-neutral-lowers-price-target-to-20
HC Wainwright & Co. Downgrades Avadel Phar...
10/23/2025 11:59:05

HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Avadel Pharmaceuticals (NASDAQ:AVDL) from Buy to Neutral and l...

alkermes-strikes-21-billion-avadel-deal-gains-access-to-narcolepsy-drug-lumryz
Alkermes Strikes $2.1 Billion Avadel Deal,...
10/22/2025 19:18:55

Alkermes agrees to acquire Avadel for $2.1 billion, adding the successful Lumryz drug and accelerating entry into sleep medicin...

beyond-the-numbers-5-analysts-discuss-avadel-pharmaceuticals-stock
Beyond The Numbers: 5 Analysts Discuss Ava...
10/22/2025 18:00:44

jefferies-downgrades-avadel-pharmaceuticals-to-hold-lowers-price-target-to-20
Jefferies Downgrades Avadel Pharmaceutical...
10/22/2025 16:07:34

Jefferies analyst Andrew Tsai downgrades Avadel Pharmaceuticals (NASDAQ:AVDL) from Buy to Hold and lowers the price target f...

needham-downgrades-avadel-pharmaceuticals-to-hold
Needham Downgrades Avadel Pharmaceuticals ...
10/22/2025 14:37:20

Needham analyst Ami Fadia downgrades Avadel Pharmaceuticals (NASDAQ:AVDL) from Buy to Hold.

trading-halt-halt-status-updated-at-71500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 7:15:...
10/22/2025 11:15:04

Core News & Articles
Alkermes To Acquire Avadel Pharmaceuticals...
10/22/2025 11:14:36

trading-halt-halted-at-65500-am-et---trading-halt-halt-news-pending
Trading Halt: Halted at 6:55:00 a.m. ET - ...
10/22/2025 10:55:06

Core News & Articles
Avadel Pharma Announces Global Settlement ...
10/22/2025 10:34:33

Avadel Pharmaceuticals plc (NASDAQ:AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, tod...

Core News & Articles
Court Orders Avadel CNS To Pay 3.85% Ongoi...
09/17/2025 15:57:16

As previously disclosed, on May 12, 2021, Jazz Pharmaceuticals, Inc. ("Jazz") filed a formal complaint initiating a law...

avadel-pharmaceuticals-to-present-lumryz-data-at-world-sleep-2025-sept-5-10
Avadel Pharmaceuticals To Present LUMRYZ D...
09/05/2025 12:04:48

hc-wainwright--co-maintains-buy-on-avadel-pharmaceuticals-raises-price-target-to-36
HC Wainwright & Co. Maintains Buy on Avade...
09/05/2025 11:51:43

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Avadel Pharmaceuticals (NASDAQ:AVDL) with a Buy and raises the ...

avadel-pharmaceuticals-enters-exclusive-global-license-agreement-with-xwpharma-to-develop-and-commercialize-valiloxybate-for-indications-including-sleep-disorders-xwpharma-to-receive-20m-upfront-and-potential-milestones
Avadel Pharmaceuticals Enters Exclusive Gl...
09/03/2025 20:32:25

what-4-analyst-ratings-have-to-say-about-avadel-pharmaceuticals
What 4 Analyst Ratings Have To Say About A...
09/03/2025 13:00:46

this-unisys-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-wednesday
This Unisys Analyst Begins Coverage On A B...
09/03/2025 12:40:11

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION